BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16368049)

  • 41. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive factors of recurrent angina after acute coronary syndrome: the global registry acute coronary events from China (Sino-GRACE).
    Zhao FH; Chen YD; Song XT; Pan WQ; Jin ZN; Yuan F; Li YB; Ren F; Lü SZ;
    Chin Med J (Engl); 2008 Jan; 121(1):12-6. PubMed ID: 18208658
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated database.
    Varas-Lorenzo C; Castellsague J; Stang MR; Tomas L; Aguado J; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):842-52. PubMed ID: 18498081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
    Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
    Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Twelve-month outcome of 658 patients with acute coronary syndrome without ST-segment elevation assigned to early invasive strategy].
    Szyguła-Jurkiewicz B; Wasilewski J; Wilczek K; Osadnik T; Trzeciak P; Lekston A; Wojnicz R; Poloński L
    Wiad Lek; 2006; 59(7-8):497-501. PubMed ID: 17209347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment and prognosis after acute coronary syndrome in an unselected patient population].
    Jensen LO; Thayssen P
    Ugeskr Laeger; 2007 Feb; 169(6):492-7. PubMed ID: 17303028
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome.
    Tang EW; Wong CK; Herbison P
    Am Heart J; 2007 Jan; 153(1):29-35. PubMed ID: 17174633
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report.
    Brener SJ; Milford-Beland S; Roe MT; Bhatt DL; Weintraub WS; Brindis RG;
    Am Heart J; 2008 Jan; 155(1):140-6. PubMed ID: 18082505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of hospitalization and follow-up care costs among patients hospitalized with ACS treated with a stent and clopidogrel.
    Chastek B; Riedel AA; Wygant G; Hauch O
    Curr Med Res Opin; 2009 Dec; 25(12):2845-52. PubMed ID: 19831706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining the outcomes of risk stratification studies of ED patients with chest pain: the marginal value of adding revascularization to the composite end point.
    Chen EH; Sites F; Shofer FS; Hollander JE
    Am J Emerg Med; 2005 Nov; 23(7):848-51. PubMed ID: 16291439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
    Arnold SV; Morrow DA; Lei Y; Cohen DJ; Mahoney EM; Braunwald E; Chan PS
    Circ Cardiovasc Qual Outcomes; 2009 Jul; 2(4):344-53. PubMed ID: 20031860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total first-year costs of acute coronary syndrome in a managed care setting.
    Etemad LR; McCollam PL
    J Manag Care Pharm; 2005 May; 11(4):300-6. PubMed ID: 15871640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic winners and losers after introduction of an effective new therapy depend on the type of payment system.
    Weintraub WS; Warner CD; Mauldin PD; Becker ER; Gomes D; Cook J; Kosinski A; Boccuzzi S
    Am J Manag Care; 1997 May; 3(5):743-9. PubMed ID: 10169536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute coronary syndrome national statistics: challenges in definitions.
    Bertoni AG; Bonds DE; Thom T; Chen GJ; Goff DC
    Am Heart J; 2005 Jun; 149(6):1055-61. PubMed ID: 15976788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.